Thai Medicinal Cannabis User Perceptions: Qualitative Study 2025
This 2025 qualitative study explores Thai medicinal cannabis user perceptions, highlighting perceived benefits and the reliance on informal peer networks. Users report benefits for cancer, pain, and insomnia but lack formal healthcare guidance. The study…
Cannabis Use and Physical Activity: Accelerometer Study Finds No Sedentary Link
Using objective accelerometer data, this study found cannabis physical activity sedentary behavior was not linked to increased inactivity or reduced vigorous exercise. A slight increase in light activity was noted but deemed clinically uncertain. These…
Childhood Trauma and Cannabis Use in Cancer Survivors
A 2025 national survey found childhood trauma cannabis use cancer survivors is significantly higher among those with adverse childhood experiences. The study highlights a fourfold increase in cannabis use among cancer survivors with high childhood…
Medical Cannabis Provider Practices: 2018 Survey Findings
The 2018 survey on medical cannabis provider practices reveals a largely self-taught field with limited formal education. Most providers recommend cannabis as a substitute for prescription drugs despite lacking formal guidelines. These findings highlight…
Cannabis Legalization and Adult Use: Who Starts Using After Legalization?
New research using 8 years of BRFSS data finds that cannabis legalization older adult health expands the pool of users primarily among groups that historically used less—older adults, women, and college-educated White Americans—rather than intensifying…
CBD and Liver Enzymes: FDA-Funded RCT Findings Explained
A 2025 FDA-funded randomized clinical trial found consumer-range CBD liver enzyme elevations in 5.6% of healthy adults. These elevations were reversible with no serious adverse events reported. This evidence highlights important safety considerations for…
Cannabis and Depression in Women: NHANES Study Findings
A NHANES study reveals cannabis depression gender differences, with women regular users showing nearly doubled odds of depressive symptoms. No similar association was found in men. The cross-sectional design limits causal conclusions.
Cannabis Mortality in Canada: What the Evidence Shows
The 2026 cannabis health costs in Canada include an estimated 28,000 to 30,000 premature deaths annually linked to cannabis use. This modeling study also analyzes land use policy by examining the potential benefits of reallocating cannabis farmland.…
Cannabis and Cognition in Older Adults: UK Biobank Study Review
The 2025 UK Biobank study on cannabis and cognition aging neuroscience examined cognitive performance in older adults with a history of cannabis use. Findings showed mixed associations, with some benefits and some risks linked to early and long-term use.…
Cannabis Dispensary Staff Counseling: Safety Gaps Revealed
A 2023 national survey reveals significant cannabis dispensary counseling gaps among staff, with many lacking addiction awareness. Most safety guidance comes from budtenders, not clinicians. State regulations show limited effect on counseling practices.